3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Vomiting
9
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Multiple Myeloma
8
Neoplasms
7
Nausea
7
Leukemia
7
Lymphoma, Non-Hodgkin
5
Lymphoma
5
Immunoglobulin Light-chain Amyloidosis
4
Breast Neoplasms
4
Polycystic Ovary Syndrome
3
Lymphoma, Follicular
3
Testicular Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
2
Sezary Syndrome
2
Sarcoma
2
Prostatic Neoplasms
2
Primary Myelofibrosis
2
Postoperative Nausea and Vomiting
2
Pdgfra-Associated Chronic Eosinophilic Leukemia
2
Ovarian Neoplasms
2
Obesity
2
Neuroblastoma
2
Myeloproliferative Disorders
2
Myelodysplastic Syndromes
2
Mycosis Fungoides
2
Lymphoma, T-Cell, Cutaneous
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large-Cell, Immunoblastic
2
Lymphoma, Large B-Cell, Diffuse
2
Interventions
Metformin
4
Progesterone
3
Inositol
2
Folic Acid
2
Estradiol
2
bicalutamide
1
Yoga
1
Thioctic Acid
1
Spironolactone
1
Phlebotomy
1
Ovidrel
1
Magnesium
1
Lactalbumin
1
Flutamide
1
Ethinyl Estradiol
1
Estrogens
1
Dexamethasone
1
Cyproterone Acetate
1
Carnitine
1
Bloodletting
1
Blood Donation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Hyperandrogenism
×
Dexamethasone
×
Clear all
NCT01421810
2023-10-27
CBS001
University of Virginia
Phase NA
Unknown
80 enrolled